{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:56:49Z","timestamp":1785859009543,"version":"3.56.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Chemoradiotherapy (cRT) and total laryngectomy (TL) are acceptable treatments for locally advanced laryngeal squamous cell carcinoma (LSSC). We aimed to compare the outcomes in patients receiving full-dose treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We identified 11,237 patients in the National Cancer Database treated 2004 to 2015 for T3-4N0-3 LSCC with either TL (with 60 to 80\u2009Gy of adjuvant RT) or cRT (70 to 80\u2009Gy). We evaluated differences in overall survival (OS) using Kaplan-Meier and Cox proportional hazards modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      For patients with T3 disease, there was no difference in OS regardless of N stage (N0: hazard ratio [HR]=0.94,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.38; N+: HR=0.92,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.19). TL was associated with improved OS in patients with T4 disease (N0: HR=1.39,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001; N+: HR=1.22,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In patients who receive optimal therapy, both TL and cRT offer similar outcomes in T3 but not T4a disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/coc.0000000000000550","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T18:05:50Z","timestamp":1557165950000},"page":"527-533","source":"Crossref","is-referenced-by-count":22,"title":["Curative-dose Chemoradiotherapy Versus Total Laryngectomy For Stage T3-T4 Squamous Cell Carcinoma of the Larynx"],"prefix":"10.1097","volume":"42","author":[{"given":"James E.","family":"Bates","sequence":"first","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Amdur","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Morris","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Hitchcock","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Dziegielewski","sequence":"additional","affiliation":[{"name":"Otolaryngology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Boyce","sequence":"additional","affiliation":[{"name":"Otolaryngology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L.","family":"Silver","sequence":"additional","affiliation":[{"name":"Otolaryngology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Shaw","sequence":"additional","affiliation":[{"name":"Surgery, University of Florida College of Medicine, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Mendenhall","sequence":"additional","affiliation":[{"name":"Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"Wolf","year":"1991","journal-title":"N Engl J Med"},{"key":"R2-20230903","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/(SICI)1097-0347(199912)21:8<689::AID-HED2>3.0.CO;2-0","article-title":"Workshop report: organ preservation strategies in advanced head and neck cancer\u2014current status and future directions","volume":"21","author":"Wolf","year":"1999","journal-title":"Head Neck"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/hed.21022","article-title":"National Cancer Database report on cancer of the head and neck: 10-year update","volume":"31","author":"Cooper","year":"2009","journal-title":"Head Neck"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mlg.0000236095.97947.26","article-title":"Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival","volume":"116","author":"Hoffman","year":"2006","journal-title":"Laryngoscope"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hed.21294","article-title":"Reexamining the treatment of advanced laryngeal cancer","volume":"32","author":"Olsen","year":"2010","journal-title":"Head Neck"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archotol.133.12.1270","article-title":"Factors predictive of survival in advanced laryngeal cancer","volume":"133","author":"Chen","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaoto.2014.1671","article-title":"Survival outcomes in advanced laryngeal cancer","volume":"140","author":"Megwalu","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"suppl 1","key":"R10-20230903","first-page":"S56","article-title":"Primary total laryngectomy versus organ preservation for T3\/T4a laryngeal cancer: a population-based analysis of survival","volume":"41","author":"Dziegielewski","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hed.24438","article-title":"Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review","volume":"38","author":"Choi","year":"2016","journal-title":"Head Neck"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/cncr.29241","article-title":"Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey","volume":"121","author":"Rosenthal","year":"2015","journal-title":"Cancer"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2015.03.004","article-title":"Total laryngectomy versus larynx preservation for T4a larynx cancer: patterns of care and survival outcomes","volume":"92","author":"Grover","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/cncr.30122","article-title":"Comparative effectiveness of surgical and nonsurgical therapy for advanced laryngeal cancer","volume":"122","author":"Lin","year":"2016","journal-title":"Cancer"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"761","DOI":"10.6004\/jnccn.2017.0101","article-title":"NCCN guidelines insights: head and neck cancers, version 2.2017","volume":"15","author":"Adelstein","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"R18-20230903","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000437","article-title":"Preradiotherapy tumor volume in local control of squamous cell carcinoma of the supraglottic larynx","author":"Nurkic","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/hed.24804","article-title":"Quantitative pretreatment CT volumetry: association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx","volume":"39","author":"Shiao","year":"2017","journal-title":"Head Neck"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/lary.24461","article-title":"Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer","volume":"124","author":"Hsin","year":"2014","journal-title":"Laryngoscope"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"e0117924","DOI":"10.1371\/journal.pone.0117924","article-title":"Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT)\/concurrent chemoradiotherapy (CCRT)","volume":"10","author":"Yabuki","year":"2015","journal-title":"PLoS ONE"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jamaoto.2016.3669","article-title":"Survival rates using individualized bioselection treatment methods in patients with advanced laryngeal cancer","volume":"143","author":"Wolf","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1586\/14737140.2013.829646","article-title":"Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer","volume":"13","author":"Vainshtein","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the National Cancer Database for Outcomes Research: a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-201906000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:01:55Z","timestamp":1785855715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201906000-00006"}},"subtitle":["An \u201cApples-to-Apples\u201d Analysis of the National Cancer Database"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000550","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}